October 20, 2025 5:50 PM
New monoclonal antibody shows early promise against malaria
A novel monoclonal antibody developed by US researchers has demonstrated strong protection against malaria in an early clinical trial, raising hopes for a new preventive approach against the deadly disease. The antibody, named MAM01, was tested by researchers at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health (CVD). The trial found that MAM01 provided dose-dependent full protection against the malaria parasite with minimal side effects. "This ...